In addition to extracellular arginine deficiency commonly observed in tumor microenvironment, the rate-limiting enzyme ASS1 responsible for intracellular de novo arginine synthesis is also frequently silenced in most cancer types10,11. This evidence concerns the gene ASS1 and cancer.